Drug responseDRUG → SHRNACell lineYM-201636, YM 201636
Across CCLE and GDSC cell-line panels, response to YM201636 is significantly associated with the shRNA dependency of multiple gene dependencies, with BONE cell lines showing a particularly strong set of associations.
The most reproducible YM201636 response-associated gene dependencies across cancer lineages are OAT, TMEM104, and SH3BP5L, each associated with drug response in up to 7 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, YM201636 response versus OAT shRNA dependency in BONE (Pearson r = 0.90).
Shrna dependency biomarkers of YM201636 response
Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.